(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-19 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 240520
Date | Daily Closing Price | Open | High | Low | Volume |
19 Tue Mar 2024 | 145.37 | 146.02 | 147.00 | 144.00 | 2.576 times |
18 Mon Mar 2024 | 147.06 | 149.99 | 150.73 | 146.77 | 0.798 times |
15 Fri Mar 2024 | 148.70 | 152.06 | 152.06 | 147.45 | 1.599 times |
14 Thu Mar 2024 | 149.89 | 154.00 | 154.85 | 149.08 | 0.972 times |
13 Wed Mar 2024 | 153.97 | 153.47 | 154.40 | 150.13 | 0.955 times |
12 Tue Mar 2024 | 153.80 | 149.20 | 155.00 | 149.20 | 1.25 times |
11 Mon Mar 2024 | 148.17 | 147.15 | 149.24 | 146.74 | 0.652 times |
08 Fri Mar 2024 | 146.62 | 146.28 | 148.84 | 144.75 | 0.817 times |
07 Thu Mar 2024 | 146.28 | 146.40 | 148.99 | 145.92 | 0.848 times |
06 Wed Mar 2024 | 146.02 | 152.50 | 152.50 | 143.89 | 0.965 times |
Stock of Ascendis Pharma (ASND) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 146.5, but if it comes above 146.5, then a intra day buy could be more profitable.
If you take a sell trade below 146.5, then use 146.5 as stoploss and 141.1 as target. However if you take a buy trade in stock , then use 146.5 as stoploss and 150.96 as target.
Share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Target | 86.55 |
Downside Target | 99.54 |
Downside Target | 101.98 |
Downside Target | 119.03 |
Downside Target | 129.25 |
Downside Target | 140.00 |
Upside Target | 150.73 |
Upside Target | 153.99 |
Upside Target | 155.00 |
Upside Target | 160.21 |
Upside Target | 161.00 |
Intraday share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Intraday Target | 142.67 |
Downside Intraday Target | 139.97 |
Upside Intraday Target | 149.4 |
Upside Intraday Target | 153.43 |
Upside Intraday Target | 146.7 |
Weekly technical analysis of Ascendis Pharma (ASND)
Date | Weekly Closing Price | Open | High | Low | Volume |
19 Tue Mar 2024 | 145.37 | 149.99 | 150.73 | 144.00 | 0.622 times |
15 Fri Mar 2024 | 148.70 | 147.15 | 155.00 | 146.74 | 1.062 times |
08 Fri Mar 2024 | 146.62 | 153.99 | 153.99 | 143.89 | 0.547 times |
01 Fri Mar 2024 | 152.47 | 158.20 | 161.00 | 142.01 | 1.717 times |
23 Fri Feb 2024 | 159.40 | 154.51 | 160.21 | 153.27 | 0.533 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
Date | Monthly Closing Price | Open | High | Low | Volume |
19 Tue Mar 2024 | 145.37 | 148.05 | 155.00 | 143.89 | 0.418 times |
29 Thu Feb 2024 | 147.76 | 130.60 | 161.00 | 129.25 | 0.977 times |
31 Wed Jan 2024 | 129.93 | 123.55 | 140.00 | 119.03 | 0.542 times |
29 Fri Dec 2023 | 125.95 | 101.00 | 129.43 | 99.54 | 1.945 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
Ascendis Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ascendis Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 148.35 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
Ascendis Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ascendis Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 148.35 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.